Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2202 in Overweight/Obese Type 2 Diabetes
NCT01674348Phase 2Terminated
- Sponsor
- Piramal Enterprises Limited
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of P2202 in type 2 diabetes mellitus (T2DM), sponsored by Piramal Enterprises Limited. Started Apr 2011; status: terminated.
02
Drugs
P2202
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01674348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674348.